APA (7th ed.) Citation

BW, S., E, B., KA, B., AI, M., JH, O., IM, S., . . . TM, B. (2020). Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 27(5), 1802. https://doi.org/10.1007/s12350-020-02139-8

Chicago Style (17th ed.) Citation

BW, Sperry, Burgett E, Bybee KA, McGhie AI, O'Keefe JH, Saeed IM, Thompson RC, and Bateman TM. "Technetium Pyrophosphate Nuclear Scintigraphy for Cardiac Amyloidosis: Imaging at 1 Vs 3 Hours and Planar Vs SPECT/CT." Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology 27, no. 5 (2020): 1802. https://doi.org/10.1007/s12350-020-02139-8.

MLA (9th ed.) Citation

BW, Sperry, et al. "Technetium Pyrophosphate Nuclear Scintigraphy for Cardiac Amyloidosis: Imaging at 1 Vs 3 Hours and Planar Vs SPECT/CT." Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology, vol. 27, no. 5, 2020, p. 1802, https://doi.org/10.1007/s12350-020-02139-8.